PATENT CLAIM ANALYSIS

Application Number: 16085972
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "359000"]

Abstract:
In an aspect, the invention relates to 1,4,5-substituted 1,2,3-triazole and 1,2,4,5-substituted imidazoles, which are modulators the pregnane X receptor (“PXR”); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of modulating an adverse drug reaction in a mammal using the compounds and pharmaceutical compositions; methods of treatment of a disorder of uncontrolled cellular proliferation, such as a cancer, using the compounds and pharmaceutical compositions; methods of modulating pregnane X receptor activity in a mammal using the compounds and pharmaceutical compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claim (Index 8):
The compound of  claim 1 , wherein the compound has a structure represented by formula:

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.90909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15519109', '16329168', '15554707', '14380659', '14421776']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8044633127645753
- 35 USC 102 Novelty (BERT): 0.5884345049591848
- Combined Prediction Score: 0.7828604319840362
- Mean Citation Score: 451.545598
- Max Citation Score: 478.9307
- Similarity Product: 444.35875448159584

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test